On June 8, 2007 eXegenics, Inc. (OTC BB: EXEG) reported that it has completed its name change to Opko Health Inc (Press release, Opko Health, JUN 8, 2007, View Source [SID:1234510719]). The company also announced its common stock has been approved for listing on the American Stock Exchange (AMEX). Opko’s stock is expected to begin trading on the AMEX exchange under the ticker symbol OPK on Monday, June 11, 2007.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Now that we are officially Opko Health, it is fitting that our shares have been approved for listing on the American Stock Exchange," said Dr. Philip Frost, chairman and CEO of Opko Health, Inc. "The improved visibility and liquidity available to us as an AMEX-listed company should contribute to our efforts to advance our ophthalmic businesses and build shareholder value."

This approval is contingent upon Opko being in compliance with all applicable listing standards on the date it begins trading on the Exchange, and may be rescinded if the company is not in compliance with such standards.